title: Cytopathology in France.
abstract: In France, organization of the cytopathology seems to be quite different from that specifically regulated in the USA and in some other European countries. The aim of this article is to underline these specificities and to describe the solutions we advocate concerning new technologies, teaching, quality assurance, national guidelines em leader, to make our current practice compatible with the international recommendations. Moreover, we highlight the peculiar status of French cytotechnologists' and comment on the recent dramatic decrease of the medical demography in France, the consequence of which may promote a controlled transfer of competence.
authors.affiliation: Department of Pathology, Lariboisière Hospital, Paris, France. beatrix.cochand-priollet@lrb.ap-hop-paris.fr
authors.forename: B
authors.initials: B
authors.lastname: Cochand-Priollet
authors.forename: S
authors.initials: S
authors.lastname: Vincent
authors.forename: P
authors.initials: P
authors.lastname: Vielh
mesh_terms: D005161:Facility Regulation and Control; D005260:Female; D005602:France; D033161:Government Regulation; D006801:Humans; D008403:Mass Screening; D010338:Pathology, Clinical / Q000458:organization & administration / Q000592:standards; D011785:Quality Assurance, Health Care; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000473:pathology; D000078329:Workforce